82 FR 11363 - National Cancer Institute; Amended Notice of Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 34 (February 22, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 34 (February 22, 2017)
| Page Range | 11363-11363 | |
| FR Document | 2017-03448 |
[Federal Register Volume 82, Number 34 (Wednesday, February 22, 2017)] [Notices] [Page 11363] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-03448] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Institute Clinical Trials and Translation Research Advisory Committee, March 8, 2017, 8:00 a.m. to March 8, 2017, 3:00 p.m., National Institutes of Health, Building 31, C-Wing, 6th Floor, Rooms 9 and 10, 31 Center Drive, Bethesda, MD 20892 which was published in the Federal Register on January 11, 2017, 81 FR 3342. This meeting notice is amended to change the meeting format and start and end times. The meeting will now be held virtually from 11:00 a.m. to 1:30 p.m. due to a change in the agenda which reduced the time required for deliberation and discussion. The meeting will still be held at the National Institutes of Health, Building 31, C-Wing, 6th Floor, Rooms 9 and 10, 31 Center Drive, Bethesda, MD 20892 and can also be accessed via NIH Videocast at https://videocast.nih.gov. This meeting is open to the public. Dated: February 16, 2017. Melanie J. Gray-Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-03448 Filed 2-21-17; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 82, No. 34 / Wednesday, February 22, 2017 / Notices 11363
therapy, or as needing alternative Contact Person: Paulette S. Gray, Ph.D., DEPARTMENT OF HEALTH AND
treatment strategies. Director, Division of Extramural Activities, HUMAN SERVICES
This notice is made in accordance National Cancer Institute—Shady Grove,
with 35 U.S.C. 209 and 37 CFR part 404. National Institutes of Health, 9609 Medical National Institutes of Health
The prospective exclusive license will Center Drive, 7th Floor, Rm. 7W444,
be royalty bearing, and the prospective Bethesda, MD 20892, 240–276–6340, grayp@ National Cancer Institute; Amended
exclusive license may be granted unless mail.nih.gov. Notice of Meeting
within fifteen (15) days from the date of Name of Committee: National Cancer Notice is hereby given of a change in
this published notice, the National Institute Board of Scientific Advisors. the meeting of the National Cancer
Cancer Institute receives written Date: March 22, 2017. Institute Clinical Trials and Translation
evidence and argument that establishes Time: 8:30 a.m. to 12:00 p.m. Research Advisory Committee, March 8,
that the grant of the license would not Agenda: Acting Director’s Report: Ongoing 2017, 8:00 a.m. to March 8, 2017, 3:00
be consistent with the requirements of and New Business; RFA and RFP Concept p.m., National Institutes of Health,
35 U.S.C. 209 and 37 CFR part 404. Reviews; and Scientific Presentations. Building 31, C-Wing, 6th Floor, Rooms
Complete applications for a license in Place: National Institutes of Health, 31 9 and 10, 31 Center Drive, Bethesda, MD
the prospective field of use that are filed Center Drive, Building 31, C-Wing, 6th Floor, 20892 which was published in the
in response to this notice will be treated Room 10, Bethesda, MD 20892. Federal Register on January 11, 2017, 81
as objections to the grant of the Contact Person: Paulette S. Gray, Ph.D., FR 3342.
contemplated Exclusive Patent License Director, Division of Extramural Activities, This meeting notice is amended to
Agreement. Comments and objections National Cancer Institute—Shady Grove, change the meeting format and start and
submitted to this notice will not be National Institutes of Health, 9609 Medical end times. The meeting will now be
Center Drive, 7th Floor, Rm. 7W444, held virtually from 11:00 a.m. to 1:30
made available for public inspection
Bethesda, MD 20892, 240–276–6340, grayp@ p.m. due to a change in the agenda
and, to the extent permitted by law, will
mail.nih.gov. which reduced the time required for
not be released under the Freedom of
Information Act, 5 U.S.C. 552. Any interested person may file written deliberation and discussion. The
comments with the committee by forwarding meeting will still be held at the National
Dated: February 15, 2017. the statement to the Contact Person listed on Institutes of Health, Building 31, C-
Richard U. Rodriguez, this notice. The statement should include the Wing, 6th Floor, Rooms 9 and 10, 31
Associate Director, Technology Transfer name, address, telephone number and when Center Drive, Bethesda, MD 20892 and
Center, National Cancer Institute. applicable, the business or professional can also be accessed via NIH Videocast
[FR Doc. 2017–03402 Filed 2–21–17; 8:45 am] affiliation of the interested person. at https://videocast.nih.gov. This
BILLING CODE 4140–01–P In the interest of security, NIH has meeting is open to the public.
instituted stringent procedures for entrance
Dated: February 16, 2017.
onto the NIH campus. All visitor vehicles,
DEPARTMENT OF HEALTH AND including taxicabs, hotel, and airport shuttles Melanie J. Gray-Pantoja,
HUMAN SERVICES will be inspected before being allowed on Program Analyst, Office of Federal Advisory
campus. Visitors will be asked to show one Committee Policy.
National Institutes of Health form of identification (for example, a [FR Doc. 2017–03448 Filed 2–21–17; 8:45 am]
government-issued photo ID, driver’s license, BILLING CODE 4140–01–P
National Cancer Institute; Notice of or passport) and to state the purpose of their
Meeting visit.
Information is also available on the DEPARTMENT OF HEALTH AND
Pursuant to section 10(a) of the
Institute’s/Center’s home page: http:// HUMAN SERVICES
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is deainfo.nci.nih.gov/advisory/bsa/bsa.htm,
where an agenda and any additional National Institutes of Health
hereby given of a meeting of the
National Cancer Institute Board of information for the meeting will be posted
National Institute on Aging; Notice of
Scientific Advisors. when available.
Closed Meeting
The meeting will be open to the (Catalogue of Federal Domestic Assistance
public, with attendance limited to space Program Nos. 93.392, Cancer Construction; Pursuant to section 10(d) of the
available. Individuals who plan to 93.393, Cancer Cause and Prevention Federal Advisory Committee Act, as
attend and need special assistance, such Research; 93.394, Cancer Detection and amended (5 U.S.C. App.), notice is
as sign language interpretation or other Diagnosis Research; 93.395, Cancer hereby given of the following meeting.
Treatment Research; 93.396, Cancer Biology The meeting will be closed to the
reasonable accommodations, should
Research; 93.397, Cancer Centers Support; public in accordance with the
notify the Contact Person listed below
93.398, Cancer Research Manpower; 93.399, provisions set forth in sections
in advance of the meeting. The meeting
Cancer Control, National Institutes of Health, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
will also be videocast and can be
HHS) as amended. The grant applications and
accessed from the NIH Videocasting and
the discussions could disclose
Podcasting Web site (http:// Dated: February 15, 2017. confidential trade secrets or commercial
videocast.nih.gov/). Melanie J. Pantoja, property such as patentable material,
Name of Committee: National Cancer Program Analyst, Office of Federal Advisory and personal information concerning
Institute Board of Scientific Advisors.
sradovich on DSK3GMQ082PROD with NOTICES
Committee Policy. individuals associated with the grant
Date: March 21, 2017. applications, the disclosure of which
[FR Doc. 2017–03387 Filed 2–21–17; 8:45 am]
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Acting Director’s Report: Ongoing BILLING CODE 4140–01–P would constitute a clearly unwarranted
and New Business; RFA and RFP Concept invasion of personal privacy.
Reviews; and Scientific Presentations. Name of Committee: National Institute on
Place: National Institutes of Health, 31 Aging Special Emphasis Panel; Second Stage
Center Drive, Building 31, C-Wing, 6th Floor, P01 Review.
Room 10, Bethesda, MD 20892. Date: March 15, 2017.
VerDate Sep<11>2014 16:05 Feb 21, 2017 Jkt 241001 PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\22FEN1.SGM 22FEN1](https://thefederalregister.org/doc/82_FR_11397/page/1.svg)
Document Created: 2017-02-22 00:08:20
Document Modified: 2017-02-22 00:08:20
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 82 FR 11363 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR